Subscribe To
Gold moves higher; outlook therapeutics shares plummet
In commodity news, oil traded down 0.1% to $81.08 while gold traded up 0.5% at $1,974.60 … fell for the fourth straight month to 93.3 in August. The...
August 30, 2023, 5:02 pm
Outlook therapeutics® provides regulatory update on fda review of ons-5010 / lytenava™ (bevacizumab-vikg) for the treatment of wet amd
FDA issues Complete Response Letter (CRL) for ONS-5010 BLA based on CMC and need for further confirmatory clinical evidence Out...
August 30, 2023, 10:00 am
Why is outlook therapeutics (otlk) stock down 78% today?
Outlook therapeutics (NASDAQ: OTLK ) stock is taking a beating on Wednesday after getting a rejection ...
August 30, 2023, 8:16 am
Outlook therapeutics collapses as fda rejects application for eye drug
Outlook therapeutics Inc (NASDAQ:OTLK) stock collapsed, losing some 70% of its value in premarket, afte...
August 30, 2023, 7:16 am
Us fda declines to approve outlook therapeutics' eye disease drug
Outlook therapeutics said on Wednesday the U.S. Food and Drug Administration declined to approve its ex...
August 30, 2023, 6:35 am
Outlook therapeutics' stock tumbles 71% premarket after fda rejects treatment for wet amd
Outlook therapeutics Inc.'s stock OTLK, +10.16% tumbled 71% in premarket trade Wednesday, after the com...
August 30, 2023, 6:29 am
Cmc markets lowers fy24 outlook, shares tumble
CMC Markets (LON: CMCX) has released a trading update today (Friday), revealing its expectations of a lower net operating income between £250 and £2...
August 25, 2023, 8:07 am
Should you buy outlook therapeutics (otlk) ahead of earnings?
Outlook therapeutics (OTLK) is seeing favorable earnings estimate revision activity and has a positive ...
August 14, 2023, 11:39 am
3 auto stocks to buy for growth & value
Investors will not want to overlook these automakers as their growth stories and valuations are very at...
August 10, 2023, 6:16 pm
Don't overlook these affordable stocks as earnings approach
Components such as valuation, growth, and rising earnings estimates help reconfirm it's time to buy these top-rated stocks for their affordable prices...
August 8, 2023, 9:11 pm
Meta beat expectations, but investors shouldn't overlook these 2 concerning numbers
Reality Labs' multibillion losses aren't going away anytime soon. Meta's growth rate hasn't been that strong in recent quarters....
August 4, 2023, 4:15 pm
Outlook therapeutics® to present at the btig virtual biotechnology conference 2023
ISELIN, N.J., Aug. 01, 2023 (GLOBE NEWSWIRE) -- Outlook therapeutics, Inc. (Nasdaq: OTLK), a biopharma...
August 1, 2023, 8:45 am
On semiconductor q2 earnings: ‘bigger trends are in our favour'
ON Semiconductor Corp (NASDAQ: ON) is in focus on Monday after reporting its financial results for the second quarter that handily topped Street estim...
July 31, 2023, 3:34 pm
With q2 earnings underway, keep an eye on the overnight session
Investors shouldn't overlook the overnight trading session, especially as earnings season gets into ful...
July 17, 2023, 6:43 pm
Don't overlook these top-rated stocks it's time to buy
Arcos Dorados (ARCO), Atlantica Sustainable Infrastructure (AY), and Lyft (LYFT) are very relevant companies in their respective industries and have t...
July 12, 2023, 9:35 pm
2 ai stocks that are screaming buys in july
Investors shouldn't overlook the role that data services will play in pushing AI forward. Artificial in...
July 12, 2023, 5:15 am
3 reasons pepsico stock is a buy
Sales in the latest quarter were up at a double-digit rate. Management has been cutting costs and raising its earnings out...
July 5, 2023, 9:45 am
Great time to own these reits - brad thomas with kirk spano
Brad Thomas talks to Kirk Spano about REITs and real estate investing. Are industrial REITs underappreciated and which US regions ...
June 26, 2023, 7:15 am
Don't overlook these consumer-centric stocks it's time to buy
With these consumer-centric stocks standing out in terms of value now appears to be a good time to buy as global economic conditions stabilize and inf...
June 14, 2023, 9:45 pm
Outlook therapeutics: august pdufa may be a buy with some caveats
OTLK is developing an ophthalmic formulation of bevacizumab. There is a logic behind this, and there's also positive data. However, certain developmen...
June 10, 2023, 1:06 am